EUVIMEDEUVIMED entdecken
Crossref

Pharmacokinetics of a three-dose regimen of intramuscular benzathine penicillin G in pregnant women with syphilis

Eshetie Melese Birru iD, Sam Salman iD, Madhu Page-Sharp, Chernet Baye, Laurens Manning iD, Brioni R Moore, Kevin T Batty

Journal of Antimicrobial Chemotherapy · 03.04.2026 · 81 (5)

DOI: 10.1093/jac/dkag145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 28.04.2026. Verfasst von Eshetie Melese Birru und 6 weiteren Autor:innen. Beteiligte Einrichtung: Curtin Medical School, Curtin University, Bentley, Western Australia, Australia. Hauptthemen laut MEDLINE: Penicillin G Benzathine, Anti-Bacterial Agents, Syphilis, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Curtin Higher Degree Research (HDR), Curtin University Strategic International Postgraduate Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Syphilis remains a global public health concern, particularly in pregnancy due to the risk of congenital syphilis. The WHO recommends benzathine penicillin G (BPG) as the standard treatment in pregnant women, whilst the optimal dosing strategy has not been established, particularly in relation to the impact of gestational age. This study sought to characterize the pharmacokinetics (PK) of a three-dose regimen of intramuscular BPG, given at weekly intervals, in pregnant women with syphilis.

Methods

A prospective PK study was undertaken in 30 pregnant Ethiopian women (second (n = 15) and third (n = 15) trimester) with syphilis (late or of unknown duration) who received three, once-weekly doses of intramuscular BPG (2.4 million units per dose). Dried blood spot samples were collected for up to 8 weeks after the first dose and benzylpenicillin concentrations quantified by liquid chromatography-mass spectrometry. Population PK analysis was performed using nonlinear, mixed-effects modelling.

Results

The PK model demonstrated biphasic absorption with a second-phase absorption half-life of 18 days. Gestational age did not impact apparent clearance or volume of distribution. Benzylpenicillin concentrations remained above the target threshold (18 ng/mL) for at least 28 days after the second dose in all women (median total cumulative time >18 ng/mL was 46 days [interquartile range 41–52 days)]. However, six participants (21%) exhibited subtherapeutic concentrations before the scheduled second injection (Day 7).

Conclusion

A three-dose, once-weekly intramuscular BPG regimen maintained therapeutic concentrations for at least 4 weeks, suggesting potentially simpler, single- or two-dose BPG regimens in pregnant women with syphilis should be evaluated for both PK exposure and clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Penicillin G BenzathineAnti-Bacterial AgentsSyphilisPregnancy Complications, InfectiousHumansFemalePregnancyInjections, IntramuscularAdultProspective StudiesYoung AdultEthiopiaChromatography, LiquidMass Spectrometry

Substanzen

Penicillin G BenzathineAnti-Bacterial Agents

Autor:innen und Institutionen

  • Curtin Medical School, Curtin University, Bentley, Western Australia, Australia.
  • Department of Pharmacology, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
  • Wesfarmers Centre for Vaccines and Infectious Diseases, The Kids Research Institute Australia Nedlands, Western Australia, Australia.
  • Medical School, University of Western Australia, Perth, Western Australia, Australia.
  • Clinical Pharmacology and Toxicology Unit, PathWest, Perth, Western Australia, Australia.
  • Department of Obstetrics and Gynaecology, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

ORCID-Profile: Eshetie Melese Birru, Sam Salman, Laurens Manning

Förderung

  • Curtin Higher Degree Research (HDR)
  • Curtin University Strategic International Postgraduate Research

Zitieren

APA

Birru, E. M., Salman, S., Page-Sharp, M., Baye, C., Manning, L., Moore, B. R., & Batty, K. T. (2026). Pharmacokinetics of a three-dose regimen of intramuscular benzathine penicillin G in pregnant women with syphilis. Journal of Antimicrobial Chemotherapy, 81(5). https://doi.org/10.1093/jac/dkag145

Vancouver

Birru EM, Salman S, Page-Sharp M, Baye C, Manning L, Moore BR, et al. Pharmacokinetics of a three-dose regimen of intramuscular benzathine penicillin G in pregnant women with syphilis. Journal of Antimicrobial Chemotherapy. 2026;81(5). doi:10.1093/jac/dkag145

BibTeX
@article{Birru2026,
  author = {Birru, Eshetie Melese and Salman, Sam and Page-Sharp, Madhu and Baye, Chernet and Manning, Laurens and Moore, Brioni R and Batty, Kevin T},
  title = {Pharmacokinetics of a three-dose regimen of intramuscular benzathine penicillin G in pregnant women with syphilis},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {5},
  doi = {10.1093/jac/dkag145}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche